Point-of-Care Diagnostics Market

Market Insights on Point-of-Care Diagnostics Market covering sales outlook, demand forecast & up-to-date key trends

Global Point-of-Care Diagnostics Market- Product –(Dipstick, Strips & Cards, Cassettes, Handheld POC Monitoring), Sample - (Saliva, Nasal Swabs, Urine, Blood, Plasma, Sweat, other fluids), Test Type – [Infectious Disease, COVID-19 Testing, Glucose Testing, Hb1Ac Testing, Coagulation Testing, Pregnancy & Fertility Testing, Allergy Tests, Cholesterol & Lipids Tests, Drug of Abuse Testing, Food Sensitivity Tests, Metabolism Tests, Vitamin D Tests, Vitamins B Test, Urinary Tract Infection Tests, Sexual Health Tests, Water Testing Kits, Alcohol Tests, Others), End User – (Hospitals, Clinics, Diagnostic Laboratories, Home Care settings, Non-Government Organization, Government & Federal Agencies, Long Term Care Centers) and Region, Forecast for 2023 – 2033

Request Sample Talk to Analyst

Global Point-of-Care Diagnostics Market Snapshot (2023 to 2033)

According to Future Market Insights research, during the projected period, the Global point-of-care diagnostics market is expected to grow at a CAGR of 6.8%. The market value is projected to increase from US$ 38.7 Billion in 2023 to US$ 74.8 Billion by 2033. The point-of-care diagnostics market was valued at US$ 36.6 Billion at the end of 2022 and is anticipated to exhibit Y-o-Y growth of 5.8% in 2023.

Market Outlook:

Data Points	Market Insights
Market Value 2022	US$ 36.6 Billion
Market Value 2023	US$ 38.7 Billion
Market Value 2033	US$ 74.8 Billion
CAGR 2023 to 2033	6.8%
Share of Top 5 Countries	56.5%
Key Players	The key players in the Global Point-of-Care Diagnostics Market Are F. Hoffmann-La Roche Ltd, Becton Dickinson & Company, Cepheid (Danaher),Siemens Healthineers, Abbott, Diasorin S.p.a., Thermo Fisher Scientific Inc. , Qiagen, BIOMÉRIEUX, Hologic Inc., Bio Rad Laboratories, Quidel Corporation, EKF Diagnostics, SEKISUI Diagnostics, DiaSys-Diagnostic Systems GmbH, InBios International, Inc., Jiangsu Mole Bioscience Co., Ltd., ACON Laboratories, Inc., Visby Medical, Inc., UNIMA, INC.

Point-of-Care testing (POCT) refers to medical diagnostic testing that is performed near the patient, usually at the bedside or in a doctor's office, rather than in a central laboratory. The goal of POCT is to provide rapid and accurate diagnostic results that can guide clinical decision-making in real-time.

The world is seeing rapid advancements in a wide range of digital health technologies, including portable and ingestible devices; mobile health apps; artificial intelligence (AI); robots used in healthcare; 3D organ printing; block chain; telemedicine; machine learning; genome research; drones; augmented and virtual reality; and electronic records. However, the market is also shifting to digitalization, so the influx of digital health technologies is a prominent driver for point-of-care diagnostic market.

Accelerating the adoption of proven digital health technologies and advancing their embedding into routine care operations has the potential to revolutionize human health by boosting efficacy, driving costs down, and increasing access to and capacity for care delivery.

New product launches and approvals such as Lab-on-a-chip technology is one of the main drivers of POCT.

For example, microbiological culture, polymerase chain reaction (PCR) and enzyme-linked immunosorbent assays (ELISA) can now be used at the Point-of-Care.
According to FDA, in Mar 2020, Cepheid received emergency use authorization from the FDA for a rapid SARS-CoV-2 test as a result of adopting a rapid disease diagnostics method.

Overall, the increasing adoption of latest technologies and new product launches and approvals is likely to boost the market in the coming years.

Don't pay for what you don't need

Customize your report by selecting specific countries or regions and save 30%!

Sales Analysis of Global Point-of-Care Diagnostics Market from 2012 to 2022 Vs Market Outlook for 2023 to 2033

Sales of the global point-of-care diagnostics market grew at a CAGR of 6.2% between 2012 to 2022. Global point-of-care diagnostics market contributes 40.0% revenue share to the global in-vitro diagnostics market valued at US$ 91.2 Billion in 2022.

The increasing prevalence of Infectious diseases has resulted in higher uptake of POC diagnostic options such as Glucose and Hb1Ac testing. Because of their easy availability and rapid diagnosis, point-of-care diagnostics are typically the first form of testing recommended worldwide.

A significant advance has been made in the effort to identify SARS-CoV-2 coronavirus patients with the addition of saliva samples for the purpose of coronavirus identification. Governments concentrated on raising knowledge about COVID-19 testing during the COVID-19 epidemic to ensure an early identification of the illness. As a result of such initiatives, people become more knowledgeable of Point-of-Care testing for the diagnosis of coronavirus.

Creating awareness about diseases is an essential aspect of early detection and screening. If the public has a general understanding of diseases and symptoms, action plans can be better implemented. On the other hand, if there is a lack of awareness, it stops people from taking preventive measures or availing treatments.

Considering this, FMI expects the global market to grow at a CAGR of 6.8% through the forecasted years.

What are the Key Opportunities for Players in the Global Point-of-Care Diagnostics Market?

There is a lack of expansion of biotechnology & pharmaceutical Industries regarding point-of-care diagnostics. Biopharmaceuticals are one of modern science's most technically advanced and exquisite achievements. Pharmaceutical companies are putting in a lot of effort to produce medications and lifesaving vaccines and biologicals for the entire world. When the pharmaceutical sector employs biotechnological advancements and advanced processes, the result is better and faster drug delivery. Biotechnology has aided the pharmaceutical sector in the correct manufacturing of vaccines and medications.

The pharmaceutical sector intends to establish products that support the treatment of various diseases. This may result in pharma companies manufacturing point-of-Care (POC) devices.

While greater investment for innovative products is required for the growth of the market, the healthcare infrastructure can have a substantial impact on market expansion. Most healthcare authorities have recently committed increased financing for the development and enhancement of their healthcare infrastructure as a result of the COVID-19 pandemic. The development of Point-of-Care diagnostics kits and their production need more investment.

Overall, healthcare infrastructure for POCT is complex and evolving, and it is important that companies stay abreast of regulatory changes and work closely with regulators to ensure compliance. However, regulatory initiatives that promote safe and effective pain management can create growth opportunities for the POCT market, especially for companies that offer innovative solutions.

Increased testing of point-of-care diagnosis in patients will pave the way for new technology and treatment options, ultimately leading more improvement in healthcare infrastructure and growth in number of manufacturing facilities.

Sabyasachi Ghosh

Principal Consultant

Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

Talk to Analyst

Which Factors Could Possibly Restrain the Growth of Global Market?

Point-of-Care tests in some therapy areas have become more accurate (e.g., glucose testing). Overall, POC tests and rapid tests tend to remain less accurate compared to tests run in a laboratory. Accuracy is essential in medical testing, because an incorrect diagnosis can lead to inappropriate treatment, which can have serious consequences for patients. Inaccurate POC results can lead to false positives or false negatives, which can result in unnecessary treatment or missed diagnosis, respectively.

Inaccurate POCT results can also lead to mistrust in the technology, which can impact the adoption and utilization of POCT products. Healthcare providers may be hesitant to rely on POCT if they have concerns about its accuracy and reliability.

The cost of tests and a lack of trust in POC/ rapid testing are major concerns around the globe. The cost of point-of-care kits or devices is very high as compared to laboratory tests, which is compounded by the lower level of accuracy offered by the former.

Due to financial constraints, academic research laboratories are often unable to purchase expensive equipment. The overall cost of these instruments increases as a result of maintenance costs and other indirect expenses. Thus, the higher cost associated with the equipment and other factors causing unaffordability for the laboratories might hamper the market growth.

Due to less funding from governments and private funders, POCT devices cost more than regular laboratory tests, which hampers the growth of the point-of-care testing market.

These factors are expected to hamper revenue growth of the global market over the forecast period.

Country-wise Insights

What Makes the USA the Dominating Country in the Global Market?

USA dominated the global market in 2022 and is further expected to register growth rate at CAGR of 6.8%.

Diagnostic techniques, such as rapid testing or POCT like COVID-19 testing, glucose testing, and allergy tests, etc., has seen a high rate of patient acceptance as a result of the high prevalence. Awareness campaigns and strategic conferences with focus on point-of-care technologies for healthcare sector, has been undertaken by various associations in USA

In May 2022, American Association for Clinical Chemistry, organized a Point-of-Care testing boot camp for POCT professionals and experts in the lab medicine community.
Why is Germany considered to be a Lucrative Market for Point-of-Care Diagnostics?

Germany dominated the European market with value share of 25.2% in 2022

The general physicians in primary care settings in Germany highly prefer POCTs as a useful diagnostic tool. There are numerous POCTs available in the German market. In the past few years, due to COVID-19 point-of-care diagnostics has been of tremendous importance as first line of defense for testing purpose.

The safe and successful use of point-of-care diagnostics in Germany is likely to influence other European countries to also opt for this method, ultimately resulting in market expansion.

What Makes China an Emerging Market for Global Point-of-Care Diagnostics?

China is projected to be the most attractive market in the east Asia point-of-care diagnostics and is expected to grow over a significant CAGR of 9.0% over the forecast period.

Point-of-care diagnostics market in China is expected to grow significantly in the coming years due to several factors.

One of the main factors driving the growth of the point-of-care diagnostics market in China is the increasing awareness of the condition among the general public and healthcare professionals. As more people become aware of the POC testing, they are more likely to adapt to the testing method, which is leading to increased demand for testing for Point-of-care diagnostics.

Another factor contributing to the growth of the Chinese market is the increasing availability of advanced medical technologies. China has made significant investments in its healthcare infrastructure, and many new hospitals and clinics have been built in recent years.

Category-wise Insights

Why COVID-19 Testing held the Dominant Position within the Global Market?

The COVID-19 testing diagnostic segment held the major chunk of about 15.1% in global market by the end of 2022. However, food sensitivity testing is the most lucrative segment over the forecast period due to increase in food allergic cases. Many of allergic reactions require rapid diagnosis that’s where point-of-care diagnostics plays a significant role.

Which Sample Type is Adopted the Most in Point-of-Care Diagnostics in 2022?

Nasal swabs segment accounted for revenue share of 28.4% in the global market at the end of 2022.

A nasopharyngeal swab, one type of nasal swab, is a test used to look for bacteria or viruses that cause respiratory infections. Your healthcare provider uses a swab to take a small sample of cells from your nasopharynx, the top part of your nose and throat.

Overall, nasal swabs offers a convenient sample type for point-of-care diagnostics for sample withdrawal, making it the largest sample type for this segment.

Which Product of Point-of-Care Diagnostics dominates the Global Market in 2022?

Handheld POC Monitoring Devices segment accounted for revenue share of 41.3% in the global market at the end of 2022.

Handheld POC monitoring devices can be used to monitor a wide range of medical conditions, such as diabetes, cardiovascular disease, and infectious diseases. For example, a handheld blood glucose meter can be used by patients with diabetes to monitor their blood sugar levels, while a handheld device that measures blood pressure can be used to monitor patients with hypertension.

Overall, Handheld POC Monitoring Devices offers a convenient Product type for Global Point-of-Care diagnostics treating products, making it the largest Product for this segment.

Why Hospitals held the Dominant Position within the Global Market?

Hospitals held the major chunk of about 27.7% in global market by the end of 2022.

Hospitals offers a convenient end user for POCT market conducting POC tests, making it the dominant end user for this segment. Hospitals segment is set to be highly lucrative in the upcoming years due to ease and access of POCT.

Competitive Landscape

Collaboration are the top strategy being adopted by leading players to expand their product portfolio, their customer base as well as maintain their foothold in the market.

For instance:

The Elecsys Amyloid Plasma Panel (EAPP), a cutting-edge blood test from Roche Diagnostics that seeks to aid in the early identification of Alzheimer's disease, was developed in collaboration with Eli Lilly in March 2023.
Roche and Pfizer collaborated in the United States in December 2022 to assist patients, who test positive with COVID-19, in navigating risks, symptoms, testing, and treatment choices.

Similarly, recent developments have been tracked by the team at Future Market Insights related to companies in the Point-of-care Diagnostics Market space, which are available in the full report

Scope of the Global Point-of-Care Diagnostics Industry Report

Attribute	Details
Forecast Period	2023 to 2033
Historical Data Available for	2012 to 2022
Market Analysis	USD Million for Value
Key Regions Covered	North America, Latin America, Europe, South Asia, East Asia, Oceania, Middle East and Africa (MEA)
Key Countries Covered	USA, Canada, Brazil, Mexico, Argentina, Germany, UK, France, Italy, Spain, Russia, BENELUX, China, Japan, South Korea, India, Thailand, Indonesia, Malaysia, Australia, New Zealand, Türkiye, South Africa, and GCC Countries
Key Segments Covered	Test Type, Sample, Product, End User, Region
Key Companies Profiled	F. Hoffmann-La Roche Ltd Becton Dickinson & Company Cepheid (Danaher) Siemens Healthineers Abbott Diasorin S.p.a. Thermo Fisher Scientific Inc. Qiagen BIOMÉRIEUX Hologic Inc. Bio Rad Laboratories Quidel Corporation EKF Diagnostics SEKISUI Diagnostics DiaSys-Diagnostic Systems GmbH InBios International, Inc. Jiangsu Mole Bioscience Co., Ltd. ACON Laboratories, Inc. Visby Medical, Inc. UNIMA, INC.
Report Coverage	Market Forecast, Competition Intelligence, DROT Analysis, Market Dynamics and Challenges, Strategic Growth Initiatives
Customization & Pricing	Available upon Request

Key Segments Covered in Global Point-of-Care Diagnostics Industry Research

By Product:

Dipstick
Strips & Cards
Cassettes
Handheld POC Monitoring Devices

By Sample:

Saliva
Nasal Swabs
Urine
Blood
Plasma
Sweat
Other Fluids

By Test Type:

COVID-19 Testing
Glucose Testing
Hb1Ac Testing
Coagulation Testing
Pregnancy & Fertility Testing
Allergy Tests
Cholesterol & Lipids Tests
Drug of Abuse (DOA) Testing
Food Sensitivity Tests
Metabolism Tests
Vitamin D Tests
Vitamins B Test
Urinary Tract Infection (UTI) Tests
Sexual Health Tests
Water Testing Kits
Alcohol Tests
Others
Infectious Disease
- HIV POC Testing
- Clostridium Difficile POC Testing
- HBV POC Testing
- Pneumonia or Streptococcus Associated Infections Testing
- Respiratory Syncytial Virus (RSV) POC Testing
- HPV POC
- Influenza/Flu POC Testing
- HCV POC Testing
- MRSA POC Testing
- TB and Drug-resistant TB POC Testing & HSV POC Testing

By End User:

Hospitals
Clinics
Diagnostic Laboratories
Home Care Settings
Non-Government Organization
Government & Federal Agencies
Long Term Care Centers

By Region:

North America
Latin America
Europe
South Asia
East Asia
Oceania
Middle East and Africa (MEA)

Frequently Asked Questions

How much is the global market currently worth?

The global market is valued around US$ 36.6 Billion in 2022.

What is the global market estimated reach in 2023?

The global market estimates for 2023 is around US$ 38.7 Billion.

What is the sales forecast for the global market till 2033?

The global market is expected to reach US$ 74.8 Billion by the end of 2033, with sales revenue expected to be 6.8% CAGR through 2033.

Which region dominated the global market in 2022?

North America dominated the global market in 2022 with the USA being the leading contributor in the North American region.

Which Test Type segment will create lucrative opportunity by 2033?

food sensitivity testing segment is the most lucrative segment and is ecpected to grow at a CAGR of close to 9.5% over the forecast period.

What are the top countries driving demand for the market?

The USA, Germany, China, Japan and France are the top countries that are driving the demand for point-of-care diagnostics globally.

What was the last ten year’s CAGR for the global market?

From 2012 to 2022, the market for point-of-care diagnostics expanded at a rate of 6.2%.

Which are the leading companies in the Global Market?

F. Hoffmann-La Roche Ltd, Becton Dickinson & Company, Cepheid (Danaher), Siemens Healthineers, Abbott, Diasorin S.p.a., Thermo Fisher Scientific Inc., Qiagen are the key players within the global market.

What is the China market outlook?

China is projected to grow with CAGR of 9.0% over the forecast duration.

What is the Germany market outlook?

Germany held a 25.2% value share in the European market in 2022.

Table of Content

1. Executive Summary

1.1. Global Market Outlook

1.2. Demand Side Trends

1.3. Supply-Side Trends

1.4. Analysis and Recommendations

2. Market Overview

2.1. Market Coverage / Taxonomy

2.2. Market Definition / Scope / Limitations

2.3. Inclusions and Exclusions

3. Key Market Trends

3.1. Key Trends Impacting the Market

3.2. Development/Innovation Trends

4. Value-Added Insights

4.1. Disease Epidemiology, By Indication

4.2. Regulatory Scenario

4.3. Reimbursement Landscape

4.4. Unmet Needs and Opportunities

4.5. Point-of-care Testing (POCT) Compared to a Conventional Testing Procedure

4.6. Challenges and Benefits of POCT

4.7. PESTLE Analysis

4.8. Porter’s Analysis

4.9. Value Chain Analysis

4.10. Parent Market Analysis

5. Market Background

5.1. Macro-Economic Factors

5.1.1. Global GDP Growth Outlook

5.1.2. Global Healthcare Expenditure

5.1.3. Global In-vitro Diagnostics Market

5.2. Forecast Factors - Relevance & Impact

5.2.1. Top Companies Historical Growth

5.2.2. Increasing Treatment Seeking Rate

5.2.3. New Test Type Launches/Approvals

5.2.4. Increasing Diagnosis Rate (%) of Infectious Diseases

5.2.5. Increasing Incidence of Chronic Diseases

5.2.6. Rising Adoption of POC Devices

5.2.7. Government Initiatives to Combat Diseases

5.2.8. Companies Increasingly Spending on R&D and Focus on Innovation

5.2.9. Collaborations and Agreements between Manufacturers

5.3. Market Dynamics

5.3.1. Drivers

5.3.2. Restraints

5.3.3. Opportunity Analysis

6. COVID-19 Crisis - Impact Assessment

6.1. COVID-19 and Impact Analysis

6.1.1. By Test Type

6.1.2. By Product

6.1.3. By Sample

6.1.4. By End User

6.1.5. By Country

6.2. 2022 Market Scenario

7. Global Market Demand Volume (Units) Analysis 2012 to 2022 and Forecast, 2023 to 2033

7.1. Historical Market Volume Analysis, 2012 to 2022

7.2. Current and Future Market Volume Projections, 2023 to 2033

7.2.1. Y-o-Y Growth Trend Analysis

8. Global Market - Pricing Assessment

8.1. Global Pricing Analysis

8.2. Pricing Assumptions

9. Global Market Demand (in Value or Size in US$ Mn) Analysis 2012 to 2022 and Forecast, 2023 to 2033

9.1. Historical Market Value (US$ Million) Analysis, 2012 to 2022

9.2. Current and Future Market Value (US$ Million) Projections, 2023 to 2033

9.2.1. Y-o-Y Growth Trend Analysis

9.2.2. Absolute $ Opportunity Analysis

10. Global Market Analysis 2012 to 2022 and Forecast 2023 to 2033, By Test Type

10.1. Introduction / Key Findings

10.2. Historical Market Size (US$ Million) Analysis by Test Type, 2012 to 2022

10.3. Current and Future Market Size (US$ Million) Analysis and Forecast by Test Type, 2023 to 2033

10.3.1. Infectious Disease

10.3.1.1. HIV POC Testing

10.3.1.2. Clostridium Difficile POC Testing

10.3.1.3. HBV POC Testing

10.3.1.4. Pneumonia or Streptococcus Associated Infections Testing

10.3.1.5. Respiratory Syncytial Virus (RSV) POC Testing

10.3.1.6. HPV POC

10.3.1.7. Influenza/Flu POC Testing

10.3.1.8. HCV POC Testing

10.3.1.9. MRSA POC Testing

10.3.1.10. TB and Drug-resistant TB POC Testing

10.3.1.11. HSV POC Testing

10.3.2. COVID-19 Testing

10.3.3. Glucose Testing

10.3.4. Hb1Ac Testing

10.3.5. Coagulation Testing

10.3.6. Pregnancy & Fertility Testing

10.3.7. Allergy Tests

10.3.8. Cholesterol & Lipids Tests

10.3.9. Drug of Abuse (DOA) Testing

10.3.10. Food Sensitivity Tests

10.3.11. Metabolism Tests

10.3.12. Vitamin D Tests

10.3.13. Vitamins B Test

10.3.14. Urinary Tract Infection (UTI) Tests

10.3.15. Sexual Health Tests

10.3.16. Water Testing Kits

10.3.17. Alcohol Tests

10.3.18. Others

10.4. Market Attractiveness Analysis by Test Type

11. Global Market Analysis 2012 to 2022 and Forecast 2023 to 2033, By Product

11.1. Introduction / Key Findings

11.2. Historical Market Size (US$ Million) Analysis & Volume Analysis by Product, 2012 to 2022

11.3. Current and Future Market Size (US$ Million) & Volume Analysis and Forecast by Product, 2023 to 2033

11.3.1. Dipstick

11.3.2. Strips & Cards

11.3.3. Cassettes

11.3.4. Handheld POC Monitoring Devices

11.4. Market Attractiveness Analysis by Product

12. Global Market Analysis 2012 to 2022 and Forecast 2023 to 2033, By Sample

12.1. Introduction / Key Findings

12.2. Historical Market Size (US$ Million) Analysis by Sample, 2012 to 2022

12.3. Current and Future Market Size (US$ Million) Analysis and Forecast by Sample, 2023 to 2033

12.3.1. Saliva

12.3.2. Nasal Swabs

12.3.3. Urine

12.3.4. Blood

12.3.5. Plasma

12.3.6. Sweat

12.3.7. Other Fluids

12.4. Market Attractiveness Analysis by Product

13. Global Market Analysis 2012 to 2022 and Forecast 2023 to 2033, By End User

13.1. Introduction / Key Findings

13.2. Historical Market Size (US$ Million) Analysis by End User, 2012 to 2022

13.3. Current and Future Market Size (US$ Million) Analysis and Forecast by End User, 2023 to 2033

13.3.1. Hospitals

13.3.2. Clinics

13.3.3. Diagnostic Laboratories

13.3.4. Home Care Settings

13.3.5. Non-Government Organization

13.3.6. Government & Federal Agencies

13.3.7. Long-Term Care Centers

13.4. Market Attractiveness Analysis by End User

14. Global Market Analysis 2012 to 2022 and Forecast 2023 to 2033, By Region

14.1. Introduction / Key Findings

14.2. Historical Market Size (US$ Million) and Volume (Units) Analysis by Region, 2012 to 2022

14.3. Current and Future Market Size (US$ Million) and Volume (Units) Analysis and Forecast by Region, 2022-2032

14.3.1. North America

14.3.2. Latin America

14.3.3. Europe

14.3.4. South Asia

14.3.5. East Asia

14.3.6. Oceania

14.3.7. Middle East & Africa

14.4. Market Attractiveness Analysis by Country

15. North America Market Analysis 2012 to 2022 and Forecast 2023 to 2033

15.1. Introduction

15.2. Historical Market Size (US$ Million) and Volume (Units) Analysis by Market Taxonomy, 2012 to 2022

15.3. Current and Future Market Size (US$ Million) and Volume (Units) Analysis and Forecast by Market Taxonomy, 2023 to 2033

15.3.1. By Country

15.3.1.1. USA

15.3.1.2. Canada

15.3.2. By Test Type

15.3.3. By Product

15.3.4. By Sample

15.3.5. By End User

15.4. Market Attractiveness Analysis

15.4.1. By Country

15.4.2. By Test Type

15.4.3. By Product

15.4.4. By Sample

15.4.5. By End User

15.5. Market Trends

15.6. Key Market Participants- Intensity Mapping

15.7. Drivers & Restraints Impact Analysis

15.8. Country-wise Analysis

15.8.1. USA Market Analysis

15.8.1.1. Introduction

15.8.1.2. Market Analysis and Forecast by Market Taxonomy

15.8.1.2.1. By Test Type

15.8.1.2.2. By Product

15.8.1.2.3. By Sample

15.8.1.2.4. By End User

15.8.2. Canada Market Analysis

15.8.2.1. Introduction

15.8.2.2. Market Analysis and Forecast by Market Taxonomy

15.8.2.2.1. By Test Type

15.8.2.2.2. By Product

15.8.2.2.3. By Sample

15.8.2.2.4. By End User

16. Latin America Market Analysis 2012 to 2022 and Forecast 2023 to 2033

16.1. Introduction

16.2. Historical Market Size (US$ Million) and Volume (Units) Analysis by Market Taxonomy, 2012 to 2022

16.3. Current and Future Market Size (US$ Million) and Volume (Units) Analysis and Forecast by Market Taxonomy, 2023 to 2033

16.3.1. By Country

16.3.1.1. Brazil

16.3.1.2. Mexico

16.3.1.3. Argentina

16.3.2. By Test Type

16.3.3. By Product

16.3.4. By Sample

16.3.5. By End User

16.4. Market Attractiveness Analysis

16.4.1. By Country

16.4.2. By Test Type

16.4.3. By Product

16.4.4. By Sample

16.4.5. By End User

16.5. Market Trends

16.6. Key Market Participants- Intensity Mapping

16.7. Drivers & Restraints Impact Analysis

16.8. Country-wise Analysis

16.8.1. Brazil Market Analysis

16.8.1.1. Introduction

16.8.1.2. Market Analysis and Forecast by Market Taxonomy

16.8.1.2.1. By Test Type

16.8.1.2.2. By Product

16.8.1.2.3. By Sample

16.8.1.2.4. By End User

16.8.2. Mexico Market Analysis

16.8.2.1. Introduction

16.8.2.2. Market Analysis and Forecast by Market Taxonomy

16.8.2.2.1. By Test Type

16.8.2.2.2. By Product

16.8.2.2.3. By Sample

16.8.2.2.4. By End User

16.8.3. Argentina Market Analysis

16.8.3.1. Introduction

16.8.3.2. Market Analysis and Forecast by Market Taxonomy

16.8.3.2.1. By Test Type

16.8.3.2.2. By Product

16.8.3.2.3. By Sample

16.8.3.2.4. By End User

17. Europe Market Analysis 2012 to 2022 and Forecast 2023 to 2033

17.1. Introduction

17.2. Historical Market Size (US$ Million) and Volume (Units) Analysis by Market Taxonomy, 2012 to 2022

17.3. Current and Future Market Size (US$ Million) and Volume (Units) Analysis and Forecast by Market Taxonomy, 2023 to 2033

17.3.1. By Country

17.3.1.1. Germany

17.3.1.2. Italy

17.3.1.3. France

17.3.1.4. UK

17.3.1.5. Spain

17.3.1.6. BENELUX

17.3.1.7. Russia

17.3.2. By Test Type

17.3.3. By Product

17.3.4. By Sample

17.3.5. By End User

17.4. Market Attractiveness Analysis

17.4.1. By Country

17.4.2. By Test Type

17.4.3. By Product

17.4.4. By Sample

17.4.5. By End User

17.5. Market Trends

17.6. Key Market Participants- Intensity Mapping

17.7. Drivers & Restraints Impact Analysis

17.8. Country-wise Analysis

17.8.1. Germany Market Analysis

17.8.1.1. Introduction

17.8.1.2. Market Analysis and Forecast by Market Taxonomy

17.8.1.2.1. By Test Type

17.8.1.2.2. By Product

17.8.1.2.3. By Sample

17.8.1.2.4. By End User

17.8.2. Italy Market Analysis

17.8.2.1. Introduction

17.8.2.2. Market Analysis and Forecast by Market Taxonomy

17.8.2.2.1. By Test Type

17.8.2.2.2. By Product

17.8.2.2.3. By Sample

17.8.2.2.4. By End User

17.8.3. France Market Analysis

17.8.3.1. Introduction

17.8.3.2. Market Analysis and Forecast by Market Taxonomy

17.8.3.2.1. By Test Type

17.8.3.2.2. By Product

17.8.3.2.3. By Sample

17.8.3.2.4. By End User

17.8.4. UK Market Analysis

17.8.4.1. Introduction

17.8.4.2. Market Analysis and Forecast by Market Taxonomy

17.8.4.2.1. By Test Type

17.8.4.2.2. By Product

17.8.4.2.3. By Sample

17.8.4.2.4. By End User

17.8.5. Spain Market Analysis

17.8.5.1. Introduction

17.8.5.2. Market Analysis and Forecast by Market Taxonomy

17.8.5.2.1. By Test Type

17.8.5.2.2. By Product

17.8.5.2.3. By Sample

17.8.5.2.4. By End User

17.8.6. BENELUX Market Analysis

17.8.6.1. Introduction

17.8.6.2. Market Analysis and Forecast by Market Taxonomy

17.8.6.2.1. By Test Type

17.8.6.2.2. By Product

17.8.6.2.3. By Sample

17.8.6.2.4. By End User

17.8.7. Russia Market Analysis

17.8.7.1. Introduction

17.8.7.2. Market Analysis and Forecast by Market Taxonomy

17.8.7.2.1. By Test Type

17.8.7.2.2. By Product

17.8.7.2.3. By Sample

17.8.7.2.4. By End User

18. South Asia Market Analysis 2012 to 2022 and Forecast 2023 to 2033

18.1. Introduction

18.2. Historical Market Size (US$ Million) and Volume (Units) Analysis by Market Taxonomy, 2012 to 2022

18.3. Current and Future Market Size (US$ Million) and Volume (Units) Analysis and Forecast by Market Taxonomy, 2023 to 2033

18.3.1. By Country

18.3.1.1. India

18.3.1.2. Indonesia

18.3.1.3. Malaysia

18.3.1.4. Thailand

18.3.1.5. Rest of South Asia

18.3.2. By Test Type

18.3.3. By Product

18.3.4. By Sample

18.3.5. By End User

18.4. Market Attractiveness Analysis

18.4.1. By Country

18.4.2. By Test Type

18.4.3. By Product

18.4.4. By Sample

18.4.5. By End User

18.5. Market Trends

18.6. Key Market Participants- Intensity Mapping

18.7. Drivers & Restraints Impact Analysis

18.8. Country-wise Analysis

18.8.1. India Market Analysis

18.8.1.1. Introduction

18.8.1.2. Market Analysis and Forecast by Market Taxonomy

18.8.1.2.1. By Test Type

18.8.1.2.2. By Product

18.8.1.2.3. By Sample

18.8.1.2.4. By End User

18.8.2. Indonesia Market Analysis

18.8.2.1. Introduction

18.8.2.2. Market Analysis and Forecast by Market Taxonomy

18.8.2.2.1. By Test Type

18.8.2.2.2. By Product

18.8.2.2.3. By Sample

18.8.2.2.4. By End User

18.8.3. Malaysia Market Analysis

18.8.3.1. Introduction

18.8.3.2. Market Analysis and Forecast by Market Taxonomy

18.8.3.2.1. By Test Type

18.8.3.2.2. By Product

18.8.3.2.3. By Sample

18.8.3.2.4. By End User

18.8.4. Thailand Market Analysis

18.8.4.1. Introduction

18.8.4.2. Market Analysis and Forecast by Market Taxonomy

18.8.4.2.1. By Test Type

18.8.4.2.2. By Product

18.8.4.2.3. By Sample

18.8.4.2.4. By End User

19. East Asia Market Analysis 2012 to 2022 and Forecast 2023 to 2033

19.1. Introduction

19.2. Historical Market Size (US$ Million) and Volume (Units) Analysis by Market Taxonomy, 2012 to 2022

19.3. Current and Future Market Size (US$ Million) and Volume (Units) Analysis and Forecast by Market Taxonomy, 2023 to 2033

19.3.1. By Country

19.3.1.1. China

19.3.1.2. Japan

19.3.1.3. South Korea

19.3.2. By Test Type

19.3.3. By Product

19.3.4. By Sample

19.3.5. By End User

19.4. Market Attractiveness Analysis

19.4.1. By Country

19.4.2. By Test Type

19.4.3. By Product

19.4.4. By Sample

19.4.5. By End User

19.5. Market Trends

19.6. Key Market Participants- Intensity Mapping

19.7. Drivers & Restraints Impact Analysis

19.8. Country-wise Analysis

19.8.1. China Market Analysis

19.8.1.1. Introduction

19.8.1.2. Market Analysis and Forecast by Market Taxonomy

19.8.1.2.1. By Test Type

19.8.1.2.2. By Product

19.8.1.2.3. By Sample

19.8.1.2.4. By End User

19.8.2. Japan Market Analysis

19.8.2.1. Introduction

19.8.2.2. Market Analysis and Forecast by Market Taxonomy

19.8.2.2.1. By Test Type

19.8.2.2.2. By Product

19.8.2.2.3. By Sample

19.8.2.2.4. By End User

19.8.3. South Korea Market Analysis

19.8.3.1. Introduction

19.8.3.2. Market Analysis and Forecast by Market Taxonomy

19.8.3.2.1. By Test Type

19.8.3.2.2. By Product

19.8.3.2.3. By Sample

19.8.3.2.4. By End User

20. Oceania Market Analysis 2012 to 2022 and Forecast 2023 to 2033

20.1. Introduction

20.2. Historical Market Size (US$ Million) and Volume (Units) Analysis by Market Taxonomy, 2012 to 2022

20.3. Current and Future Market Size (US$ Million) and Volume (Units) Analysis and Forecast by Market Taxonomy, 2023 to 2033

20.3.1. By Country

20.3.1.1. Australia

20.3.1.2. New Zealand

20.3.2. By Test Type

20.3.3. By Product

20.3.4. By Sample

20.3.5. By End User

20.4. Market Attractiveness Analysis

20.4.1. By Country

20.4.2. By Test Type

20.4.3. By Product

20.4.4. By Sample

20.4.5. By End User

20.5. Market Trends

20.6. Key Market Participants- Intensity Mapping

20.7. Drivers & Restraints Impact Analysis

20.8. Country-wise Analysis

20.8.1. Australia Market Analysis

20.8.1.1. Introduction

20.8.1.2. Market Analysis and Forecast by Market Taxonomy

20.8.1.2.1. By Test Type

20.8.1.2.2. By Product

20.8.1.2.3. By Sample

20.8.1.2.4. By End User

20.8.2. New Zealand Market Analysis

20.8.2.1. Introduction

20.8.2.2. Market Analysis and Forecast by Market Taxonomy

20.8.2.2.1. By Test Type

20.8.2.2.2. By Product

20.8.2.2.3. By Sample

20.8.2.2.4. By End User

21. Middle East & Africa Market Analysis 2012 to 2022 and Forecast 2023 to 2033

21.1. Introduction

21.2. Historical Market Size (US$ Million) and Volume (Units) Analysis by Market Taxonomy, 2012 to 2022

21.3. Current and Future Market Size (US$ Million) and Volume (Units) Analysis and Forecast by Market Taxonomy, 2023 to 2033

21.3.1. By Country

21.3.1.1. GCC Country

21.3.1.2. Türkiye

21.3.1.3. South Africa

21.3.1.4. Rest of MEA

21.3.2. By Test Type

21.3.3. By Product

21.3.4. By Sample

21.3.5. By End User

21.4. Market Attractiveness Analysis

21.4.1. By Country

21.4.2. By Test Type

21.4.3. By Product

21.4.4. By Sample

21.4.5. By End User

21.5. Market Trends

21.6. Key Market Participants- Intensity Mapping

21.7. Drivers & Restraints Impact Analysis

21.8. Country-wise Analysis

21.8.1. GCC Country Market Analysis

21.8.1.1. Introduction

21.8.1.2. Market Analysis and Forecast by Market Taxonomy

21.8.1.2.1. By Test Type

21.8.1.2.2. By Product

21.8.1.2.3. By Sample

21.8.1.2.4. By End User

21.8.2. Türkiye Market Analysis

21.8.2.1. Introduction

21.8.2.2. Market Analysis and Forecast by Market Taxonomy

21.8.2.2.1. By Test Type

21.8.2.2.2. By Product

21.8.2.2.3. By Sample

21.8.2.2.4. By End User

21.8.3. South Africa Market Analysis

21.8.3.1. Introduction

21.8.3.2. Market Analysis and Forecast by Market Taxonomy

21.8.3.2.1. By Test Type

21.8.3.2.2. By Product

21.8.3.2.3. By Sample

21.8.3.2.4. By End User

22. Market Structure Analysis

22.1. Market Analysis by Tier of Companies

22.2. Market Share Analysis of Top Players (%)

22.3. Market Concentration

22.4. Market Presence Analysis

23. Competition Analysis

23.1. Competition Dashboard

23.2. Key Development Analysis

23.3. Branding and Promotional Strategies, By Key Players

23.4. Competition Deep Dive

23.4.1. F. Hoffmann-La Roche Ltd

23.4.1.1. Overview

23.4.1.2. Product Portfolio

23.4.1.3. Key Financials

23.4.1.4. SWOT Analysis

23.4.1.5. Key Developments

23.4.1.6. Sales Footprint

23.4.1.7. Strategy Overview

23.4.1.7.1. Marketing Strategy

23.4.1.7.2. Product Strategy

23.4.1.7.3. Channel Strategy

23.4.2. Becton Dickinson & Company

23.4.2.1. Overview

23.4.2.2. Product Portfolio

23.4.2.3. Key Financials

23.4.2.4. SWOT Analysis

23.4.2.5. Key Developments

23.4.2.6. Sales Footprint

23.4.2.7. Strategy Overview

23.4.2.7.1. Marketing Strategy

23.4.2.7.2. Product Strategy

23.4.2.7.3. Channel Strategy

23.4.3. Cepheid (Danaher)

23.4.3.1. Overview

23.4.3.2. Product Portfolio

23.4.3.3. Key Financials

23.4.3.4. SWOT Analysis

23.4.3.5. Key Developments

23.4.3.6. Sales Footprint

23.4.3.7. Strategy Overview

23.4.3.7.1. Marketing Strategy

23.4.3.7.2. Product Strategy

23.4.3.7.3. Channel Strategy

23.4.4. Siemens Healthineers

23.4.4.1. Overview

23.4.4.2. Product Portfolio

23.4.4.3. Key Financials

23.4.4.4. SWOT Analysis

23.4.4.5. Key Developments

23.4.4.6. Sales Footprint

23.4.4.7. Strategy Overview

23.4.4.7.1. Marketing Strategy

23.4.4.7.2. Product Strategy

23.4.4.7.3. Channel Strategy

23.4.5. Abbott

23.4.5.1. Overview

23.4.5.2. Product Portfolio

23.4.5.3. Key Financials

23.4.5.4. SWOT Analysis

23.4.5.5. Key Developments

23.4.5.6. Sales Footprint

23.4.5.7. Strategy Overview

23.4.5.7.1. Marketing Strategy

23.4.5.7.2. Product Strategy

23.4.5.7.3. Channel Strategy

23.4.6. Diasorin S.p.a.

23.4.6.1. Overview

23.4.6.2. Product Portfolio

23.4.6.3. Key Financials

23.4.6.4. SWOT Analysis

23.4.6.5. Key Developments

23.4.6.6. Sales Footprint

23.4.6.7. Strategy Overview

23.4.6.7.1. Marketing Strategy

23.4.6.7.2. Product Strategy

23.4.6.7.3. Channel Strategy

23.4.7. Thermo Fisher Scientific Inc.

23.4.7.1. Overview

23.4.7.2. Product Portfolio

23.4.7.3. Key Financials

23.4.7.4. SWOT Analysis

23.4.7.5. Key Developments

23.4.7.6. Sales Footprint

23.4.7.7. Strategy Overview

23.4.7.7.1. Marketing Strategy

23.4.7.7.2. Product Strategy

23.4.7.7.3. Channel Strategy

23.4.8. Qiagen

23.4.8.1. Overview

23.4.8.2. Product Portfolio

23.4.8.3. Key Financials

23.4.8.4. SWOT Analysis

23.4.8.5. Key Developments

23.4.8.6. Sales Footprint

23.4.8.7. Strategy Overview

23.4.8.7.1. Marketing Strategy

23.4.8.7.2. Product Strategy

23.4.8.7.3. Channel Strategy

23.4.9. BIOMÉRIEUX

23.4.9.1. Overview

23.4.9.2. Product Portfolio

23.4.9.3. Key Financials

23.4.9.4. SWOT Analysis

23.4.9.5. Key Developments

23.4.9.6. Sales Footprint

23.4.9.7. Strategy Overview

23.4.9.7.1. Marketing Strategy

23.4.9.7.2. Product Strategy

23.4.9.7.3. Channel Strategy

23.4.10. Hologic Inc.

23.4.10.1. Overview

23.4.10.2. Product Portfolio

23.4.10.3. Key Financials

23.4.10.4. SWOT Analysis

23.4.10.5. Key Developments

23.4.10.6. Sales Footprint

23.4.10.7. Strategy Overview

23.4.10.7.1. Marketing Strategy

23.4.10.7.2. Product Strategy

23.4.10.7.3. Channel Strategy

23.4.11. Bio Rad Laboratories

23.4.11.1. Overview

23.4.11.2. Product Portfolio

23.4.11.3. Key Financials

23.4.11.4. SWOT Analysis

23.4.11.5. Key Developments

23.4.11.6. Sales Footprint

23.4.11.7. Strategy Overview

23.4.11.7.1. Marketing Strategy

23.4.11.7.2. Product Strategy

23.4.11.7.3. Channel Strategy

23.4.12. Quidel Corporation

23.4.12.1. Overview

23.4.12.2. Product Portfolio

23.4.12.3. Key Financials

23.4.12.4. SWOT Analysis

23.4.12.5. Key Developments

23.4.12.6. Sales Footprint

23.4.12.7. Strategy Overview

23.4.12.7.1. Marketing Strategy

23.4.12.7.2. Product Strategy

23.4.12.7.3. Channel Strategy

23.4.13. EKF Diagnostics

23.4.13.1. Overview

23.4.13.2. Product Portfolio

23.4.13.3. Key Financials

23.4.13.4. SWOT Analysis

23.4.13.5. Key Developments

23.4.13.6. Sales Footprint

23.4.13.7. Strategy Overview

23.4.13.7.1. Marketing Strategy

23.4.13.7.2. Product Strategy

23.4.13.7.3. Channel Strategy

23.4.14. SEKISUI Diagnostics

23.4.14.1. Overview

23.4.14.2. Product Portfolio

23.4.14.3. Key Financials

23.4.14.4. SWOT Analysis

23.4.14.5. Key Developments

23.4.14.6. Sales Footprint

23.4.14.7. Strategy Overview

23.4.14.7.1. Marketing Strategy

23.4.14.7.2. Product Strategy

23.4.14.7.3. Channel Strategy

23.4.15. DiaSys-Diagnostic Systems GmbH

23.4.15.1. Overview

23.4.15.2. Product Portfolio

23.4.15.3. Key Financials

23.4.15.4. SWOT Analysis

23.4.15.5. Key Developments

23.4.15.6. Sales Footprint

23.4.15.7. Strategy Overview

23.4.15.7.1. Marketing Strategy

23.4.15.7.2. Product Strategy

23.4.15.7.3. Channel Strategy

23.4.16. InBios International, Inc.

23.4.16.1. Overview

23.4.16.2. Product Portfolio

23.4.16.3. Key Financials

23.4.16.4. SWOT Analysis

23.4.16.5. Key Developments

23.4.16.6. Sales Footprint

23.4.16.7. Strategy Overview

23.4.16.7.1. Marketing Strategy

23.4.16.7.2. Product Strategy

23.4.16.7.3. Channel Strategy

23.4.17. Jiangsu Mole Bioscience Co., Ltd.

23.4.17.1. Overview

23.4.17.2. Product Portfolio

23.4.17.3. Key Financials

23.4.17.4. SWOT Analysis

23.4.17.5. Key Developments

23.4.17.6. Sales Footprint

23.4.17.7. Strategy Overview

23.4.17.7.1. Marketing Strategy

23.4.17.7.2. Product Strategy

23.4.17.7.3. Channel Strategy

23.4.18. ACON Laboratories, Inc.

23.4.18.1. Overview

23.4.18.2. Product Portfolio

23.4.18.3. Key Financials

23.4.18.4. SWOT Analysis

23.4.18.5. Key Developments

23.4.18.6. Sales Footprint

23.4.18.7. Strategy Overview

23.4.18.7.1. Marketing Strategy

23.4.18.7.2. Product Strategy

23.4.18.7.3. Channel Strategy

23.4.19. Visby Medical, Inc.

23.4.19.1. Overview

23.4.19.2. Product Portfolio

23.4.19.3. Key Financials

23.4.19.4. SWOT Analysis

23.4.19.5. Key Developments

23.4.19.6. Sales Footprint

23.4.19.7. Strategy Overview

23.4.19.7.1. Marketing Strategy

23.4.19.7.2. Product Strategy

23.4.19.7.3. Channel Strategy

23.4.20. UNIMA, INC.

23.4.20.1. Overview

23.4.20.2. Product Portfolio

23.4.20.3. Key Financials

23.4.20.4. SWOT Analysis

23.4.20.5. Key Developments

23.4.20.6. Sales Footprint

23.4.20.7. Strategy Overview

23.4.20.7.1. Marketing Strategy

23.4.20.7.2. Product Strategy

23.4.20.7.3. Channel Strategy

24. Assumptions and Acronyms Used

25. Research Methodology

List of Tables

Table 01: Global Market Value (US$ Million) Analysis and Forecast 2012 to 2033, by Test Type

Table 02: Global Market Value (US$ Million) Analysis and Forecast 2012 to 2033, by Product

Table 03: Global Market Volume (Units) Analysis and Forecast 2012 to 2033, by Product

Table 04: Global Market Value (US$ Million) Analysis and Forecast 2012 to 2033, by Sample

Table 05: Global Market Value (US$ Million) Analysis and Forecast 2012 to 2033, by End User

Table 06: Global Market Value (US$ Million) Analysis and Forecast 2012 to 2033, by Region

Table 07: North America Market Value (US$ Million) Analysis 2012-2022 and Forecast 2023 to 2033, by Country

Table 08: North America Market Value (US$ Million) Analysis and Forecast 2012 to 2033, by Test Type

Table 09: North America Market Value (US$ Million) Analysis and Forecast 2012 to 2033, by Product

Table 10: North America Market Volume (Units) Analysis and Forecast 2012 to 2033, by Product

Table 11: North America Market Value (US$ Million) Analysis and Forecast 2012 to 2033, by Sample

Table 12: North America Market Value (US$ Million) Analysis and Forecast 2012 to 2033, by End User

Table 13: Latin America Market Value (US$ Million) Analysis 2012-2022 and Forecast 2023 to 2033, by Country

Table 14: Latin America Market Value (US$ Million) Analysis and Forecast 2012 to 2033, by Test Type

Table 15: Latin America Market Value (US$ Million) Analysis and Forecast 2012 to 2033, by Product

Table 16: Latin America Market Volume (Units) Analysis and Forecast 2012 to 2033, by Product

Table 17: Latin America Market Value (US$ Million) Analysis and Forecast 2012 to 2033, by Sample

Table 18: Latin America Market Value (US$ Million) Analysis and Forecast 2012 to 2033, by End User

Table 19: Europe Market Value (US$ Million) Analysis 2012-2022 and Forecast 2023 to 2033, by Country

Table 20: Europe Market Value (US$ Million) Analysis and Forecast 2012 to 2033, by Test Type

Table 21: Europe Market Value (US$ Million) Analysis and Forecast 2012 to 2033, by Product

Table 22: Europe Market Volume (Units) Analysis and Forecast 2012 to 2033, by Product

Table 23: Europe Market Value (US$ Million) Analysis and Forecast 2012 to 2033, by Sample

Table 24: Europe Market Value (US$ Million) Analysis and Forecast 2012 to 2033, by End User

Table 25: South Asia Market Value (US$ Million) Analysis 2012-2022 and Forecast 2023 to 2033, by Country

Table 26: South Asia Market Value (US$ Million) Analysis and Forecast 2012 to 2033, by Test Type

Table 27: South Asia Market Value (US$ Million) Analysis and Forecast 2012 to 2033, by Product

Table 28: South Asia Market Volume (Units) Analysis and Forecast 2012 to 2033, by Product

Table 29: South Asia Market Value (US$ Million) Analysis and Forecast 2012 to 2033, by Sample

Table 30: South Asia Market Value (US$ Million) Analysis and Forecast 2012 to 2033, by End User

Table 31: East Asia Market Value (US$ Million) Analysis 2012-2022 and Forecast 2023 to 2033, by Country

Table 32: East Asia Market Value (US$ Million) Analysis and Forecast 2012 to 2033, by Test Type

Table 33: East Asia Market Value (US$ Million) Analysis and Forecast 2012 to 2033, by Product

Table 34: East Asia Market Volume (Units) Analysis and Forecast 2012 to 2033, by Product

Table 35: East Asia Market Value (US$ Million) Analysis and Forecast 2012 to 2033, by Sample

Table 36: East Asia Market Value (US$ Million) Analysis and Forecast 2012 to 2033, by End User

Table 37: Oceania Market Value (US$ Million) Analysis 2012-2022 and Forecast 2023 to 2033, by Country

Table 38: Oceania Market Value (US$ Million) Analysis and Forecast 2012 to 2033, by Test Type

Table 39: Oceania Market Value (US$ Million) Analysis and Forecast 2012 to 2033, by Product

Table 40: Oceania Market Volume (Units) Analysis and Forecast 2012 to 2033, by Product

Table 41: Oceania Market Value (US$ Million) Analysis and Forecast 2012 to 2033, by Sample

Table 42: Oceania Market Value (US$ Million) Analysis and Forecast 2012 to 2033, by End User

Table 43: Middle East and Africa Market Value (US$ Million) Analysis 2012-2022 and Forecast 2023 to 2033, by Country

Table 44: Middle East and Africa Market Value (US$ Million) Analysis and Forecast 2012 to 2033, by Test Type

Table 45: Middle East and Africa Market Value (US$ Million) Analysis and Forecast 2012 to 2033, by Product

Table 46: Middle East and Africa Market Volume (Units) Analysis and Forecast 2012 to 2033, by Product

Table 47: Middle East and Africa Market Value (US$ Million) Analysis and Forecast 2012 to 2033, by Sample

Table 48: Middle East and Africa Market Value (US$ Million) Analysis and Forecast 2012 to 2033, by End User

Sabyasachi Ghosh

Principal Consultant

Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

Talk to Analyst

List of Charts

Figure 01: Global Market Volume (Units), 2012 to 2022

Figure 02: Global Market Volume (Units) & Y-o-Y Growth (%) Analysis,

Figure 03: Global Point-of-Care Diagnostics, Pricing Analysis per unit (US$), in 2022

Figure 04: Global Point-of-Care Diagnostics, Pricing Forecast per unit (US$), in 2032

Figure 05: Global Market Value (US$ Million) Analysis, 2012 to 2022

Figure 06: Global Market Forecast & Y-o-Y Growth, 2023 to 2033

Figure 07: Global Market Absolute $ Opportunity (US$ Million) Analysis, 2022-2033

Figure 08: Global Market Value Share (%) Analysis 2023 and 2033, by Test Type

Figure 09: Global Market Y-o-Y Growth (%) Analysis 2022-2033, by Test Type

Figure 10: Global Market Attractiveness Analysis 2023 to 2033, by Test Type

Figure 11: Global Market Value Share (%) Analysis 2023 and 2033, by Sample

Figure 12: Global Market Y-o-Y Growth (%) Analysis 2022-2033, by Sample

Figure 13: Global Market Attractiveness Analysis 2023 to 2033, by Sample

Figure 14: Global Market Value Share (%) Analysis 2023 and 2033, by Product

Figure 15: Global Market Y-o-Y Growth (%) Analysis 2022-2033, by Product

Figure 16: Global Market Attractiveness Analysis 2023 to 2033, by Product

Figure 17: Global Market Value Share (%) Analysis 2023 and 2033, by End User

Figure 18: Global Market Y-o-Y Growth (%) Analysis 2022-2033, by End User

Figure 19: Global Market Attractiveness Analysis 2023 to 2033, by End User

Figure 20: Global Market Value Share (%) Analysis 2023 and 2033, by Region

Figure 21: Global Market Y-o-Y Growth (%) Analysis 2022-2033, by Region

Figure 22: Global Market Attractiveness Analysis 2023 to 2033, by Region

Figure 23: North America Market Value (US$ Million) Analysis, 2012 to 2022

Figure 24: North America Market Value (US$ Million) Forecast, 2023 to 2033

Figure 25: North America Market Value Share, by Test Type (2023 E)

Figure 26: North America Market Value Share, by Sample (2023 E)

Figure 27: North America Market Value Share, by Product (2023 E)

Figure 28: North America Market Value Share, by End User (2023 E)

Figure 29: North America Market Value Share, by Country (2023 E)

Figure 30: North America Market Attractiveness Analysis by Test Type, 2023 to 2033

Figure 31: North America Market Attractiveness Analysis by Sample, 2023 to 2033

Figure 32: North America Market Attractiveness Analysis by Product, 2023 to 2033

Figure 33: North America Market Attractiveness Analysis by End User, 2023 to 2033

Figure 34: North America Market Attractiveness Analysis by Country, 2023 to 2033

Figure 35: USA Market Value Proportion Analysis, 2022

Figure 36: Global Vs. USA Growth Comparison, 2022 to 2033

Figure 37: USA Market Share Analysis (%) by Test Type, 2022 & 2033

Figure 38: USA Market Share Analysis (%) by Sample, 2022 & 2033

Figure 39: USA Market Share Analysis (%) by Product, 2022 & 2033

Figure 40: USA Market Share Analysis (%) by End User, 2022 & 2033

Figure 41: Canada Market Value Proportion Analysis, 2022

Figure 42: Global Vs. Canada. Growth Comparison, 2022 to 2033

Figure 43: Canada Market Share Analysis (%) by Test Type, 2022 & 2033

Figure 44: Canada Market Share Analysis (%) by Sample, 2022 & 2033

Figure 45: Canada Market Share Analysis (%) by Product, 2022 & 2033

Figure 46: Canada Market Share Analysis (%) by End User, 2022 & 2033

Figure 47: Latin America Market Value (US$ Million) Analysis, 2012 to 2022

Figure 48: Latin America Market Value (US$ Million) Forecast, 2023 to 2033

Figure 49: Latin America Market Value Share, by Test Type (2023 E)

Figure 50: Latin America Market Value Share, by Sample (2023 E)

Figure 51: Latin America Market Value Share, by Product (2023 E)

Figure 52: Latin America Market Value Share, by End User (2023 E)

Figure 53: Latin America Market Value Share, by Country (2023 E)

Figure 54: Latin America Market Attractiveness Analysis by Test Type, 2023 to 2033

Figure 55: Latin America Market Attractiveness Analysis by Sample, 2023 to 2033

Figure 56: Latin America Market Attractiveness Analysis by Product, 2023 to 2033

Figure 57: Latin America Market Attractiveness Analysis by End User, 2023 to 2033

Figure 58: Latin America Market Attractiveness Analysis by Country, 2023 to 2033

Figure 59: Mexico Market Value Proportion Analysis, 2022

Figure 60: Global Vs Mexico Growth Comparison, 2022 to 2033

Figure 61: Mexico Market Share Analysis (%) by Test Type, 2022 & 2033

Figure 62: Mexico Market Share Analysis (%) by Sample, 2022 & 2033

Figure 63: Mexico Market Share Analysis (%) by Product, 2022 & 2033

Figure 64: Mexico Market Share Analysis (%) by End User, 2022 & 2033

Figure 65: Brazil Market Value Proportion Analysis, 2022

Figure 66: Global Vs. Brazil. Growth Comparison, 2022 to 2033

Figure 67: Brazil Market Share Analysis (%) by Test Type, 2022 & 2033

Figure 68: Brazil Market Share Analysis (%) by Sample, 2022 & 2033

Figure 69: Brazil Market Share Analysis (%) by Product, 2022 & 2033

Figure 70: Brazil Market Share Analysis (%) by End User, 2022 & 2033

Figure 71: Argentina Market Value Proportion Analysis, 2022

Figure 72: Global Vs Argentina Growth Comparison, 2022 to 2033

Figure 73: Argentina Market Share Analysis (%) by Test Type, 2022 & 2033

Figure 74: Argentina Market Share Analysis (%) by Sample, 2022 & 2033

Figure 75: Argentina Market Share Analysis (%) by Product, 2022 & 2033

Figure 76: Argentina Market Share Analysis (%) by End User, 2022 & 2033

Figure 77: Europe Market Value (US$ Million) Analysis, 2012 to 2022

Figure 78: Europe Market Value (US$ Million) Forecast, 2023 to 2033

Figure 79: Europe Market Value Share, by Test Type (2023 E)

Figure 80: Europe Market Value Share, by Sample (2023 E)

Figure 81: Europe Market Value Share, by Product (2023 E)

Figure 82: Europe Market Value Share, by End User (2023 E)

Figure 83: Europe Market Value Share, by Country (2023 E)

Figure 84: Europe Market Attractiveness Analysis by Test Type, 2023 to 2033

Figure 85: Europe Market Attractiveness Analysis by Sample, 2023 to 2033

Figure 86: Europe Market Attractiveness Analysis by Product, 2023 to 2033

Figure 87: Europe Market Attractiveness Analysis by End User, 2023 to 2033

Figure 88: Europe Market Attractiveness Analysis by Country, 2023 to 2033

Figure 89: UK Market Value Proportion Analysis, 2022

Figure 90: Global Vs. UK Growth Comparison, 2022 to 2033

Figure 91: UK Market Share Analysis (%) by Test Type, 2022 & 2033

Figure 92: UK Market Share Analysis (%) by Sample, 2022 & 2033

Figure 93: UK Market Share Analysis (%) by Product, 2022 & 2033

Figure 94: UK Market Share Analysis (%) by End User, 2022 & 2033

Figure 95: Germany Market Value Proportion Analysis, 2022

Figure 96: Global Vs. Germany Growth Comparison, 2022 to 2033

Figure 97: Germany Market Share Analysis (%) by Test Type, 2022 & 2033

Figure 98: Germany Market Share Analysis (%) by Sample, 2022 & 2033

Figure 99: Germany Market Share Analysis (%) by Product, 2022 & 2033

Figure 100: Germany Market Share Analysis (%) by End User, 2022 & 2033

Figure 101: Italy Market Value Proportion Analysis, 2022

Figure 102: Global Vs. Italy Growth Comparison, 2022 to 2033

Figure 103: Italy Market Share Analysis (%) by Test Type, 2022 & 2033

Figure 104: Italy Market Share Analysis (%) by Sample, 2022 & 2033

Figure 105: Italy Market Share Analysis (%) by Product, 2022 & 2033

Figure 106: Italy Market Share Analysis (%) by End User, 2022 & 2033

Figure 107: France Market Value Proportion Analysis, 2022

Figure 108: Global Vs France Growth Comparison, 2022 to 2033

Figure 109: France Market Share Analysis (%) by Test Type, 2022 & 2033

Figure 110: France Market Share Analysis (%) by Sample, 2022 & 2033

Figure 111: France Market Share Analysis (%) by Product, 2022 & 2033

Figure 112: France Market Share Analysis (%) by End User, 2022 & 2033

Figure 113: Spain Market Value Proportion Analysis, 2022

Figure 114: Global Vs Spain Growth Comparison, 2022 to 2033

Figure 115: Spain Market Share Analysis (%) by Test Type, 2022 & 2033

Figure 116: Spain Market Share Analysis (%) by Sample, 2022 & 2033

Figure 117: Spain Market Share Analysis (%) by Product, 2022 & 2033

Figure 118: Spain Market Share Analysis (%) by End User, 2022 & 2033

Figure 119: Russia Market Value Proportion Analysis, 2022

Figure 120: Global Vs Russia Growth Comparison, 2022 to 2033

Figure 121: Russia Market Share Analysis (%) by Test Type, 2022 & 2033

Figure 122: Russia Market Share Analysis (%) by Sample, 2022 & 2033

Figure 123: Russia Market Share Analysis (%) by Product, 2022 & 2033

Figure 124: Russia Market Share Analysis (%) by End User, 2022 & 2033

Figure 125: BENELUX Market Value Proportion Analysis, 2022

Figure 126: Global Vs BENELUX Growth Comparison, 2022 to 2033

Figure 127: BENELUX Market Share Analysis (%) by Test Type, 2022 & 2033

Figure 128: BENELUX Market Share Analysis (%) by Sample, 2022 & 2033

Figure 129: BENELUX Market Share Analysis (%) by Product, 2022 & 2033

Figure 130: BENELUX Market Share Analysis (%) by End User, 2022 & 2033

Figure 131: East Asia Market Value (US$ Million) Analysis, 2012 to 2022

Figure 132: East Asia Market Value (US$ Million) Forecast, 2023 to 2033

Figure 133: East Asia Market Value Share, by Test Type (2023 E)

Figure 134: East Asia Market Value Share, by Sample (2023 E)

Figure 135: East Asia Market Value Share, by Product (2023 E)

Figure 136: East Asia Market Value Share, by End User (2023 E)

Figure 137: East Asia Market Value Share, by Country (2023 E)

Figure 138: East Asia Market Attractiveness Analysis by Test Type, 2023 to 2033

Figure 139: East Asia Market Attractiveness Analysis by Sample, 2023 to 2033

Figure 140: East Asia Market Attractiveness Analysis by Product, 2023 to 2033

Figure 141: East Asia Market Attractiveness Analysis by End User, 2023 to 2033

Figure 142: East Asia Market Attractiveness Analysis by Country, 2023 to 2033

Figure 143: China Market Value Proportion Analysis, 2022

Figure 144: Global Vs. China Growth Comparison, 2022 to 2033

Figure 145: China Market Share Analysis (%) by Test Type, 2022 & 2033

Figure 146: China Market Share Analysis (%) by Sample, 2022 & 2033

Figure 147: China Market Share Analysis (%) by Product, 2022 & 2033

Figure 148: China Market Share Analysis (%) by End User, 2022 & 2033

Figure 149: Japan Market Value Proportion Analysis, 2022

Figure 150: Global Vs. Japan Growth Comparison, 2022 to 2033

Figure 151: Japan Market Share Analysis (%) by Test Type, 2022 & 2033

Figure 152: Japan Market Share Analysis (%) by Sample, 2022 & 2033

Figure 153: Japan Market Share Analysis (%) by Product, 2022 & 2033

Figure 154: Japan Market Share Analysis (%) by End User, 2022 & 2033

Figure 155: South Korea Market Value Proportion Analysis, 2022

Figure 156: Global Vs South Korea Growth Comparison, 2022 to 2033

Figure 157: South Korea Market Share Analysis (%) by Test Type, 2022 & 2033

Figure 158: South Korea Market Share Analysis (%) by Sample, 2022 & 2033

Figure 159: South Korea Market Share Analysis (%) by Product, 2022 & 2033

Figure 160: South Korea Market Share Analysis (%) by End User, 2022 & 2033

Figure 161: South Asia Market Value (US$ Million) Analysis, 2012 to 2022

Figure 162: South Asia Market Value (US$ Million) Forecast, 2023 to 2033

Figure 163: South Asia Market Value Share, by Test Type (2023 E)

Figure 164: South Asia Market Value Share, by Sample (2023 E)

Figure 165: South Asia Market Value Share, by Product (2023 E)

Figure 166: South Asia Market Value Share, by End User (2023 E)

Figure 167: South Asia Market Value Share, by Country (2023 E)

Figure 168: South Asia Market Attractiveness Analysis by Test Type, 2023 to 2033

Figure 169: South Asia Market Attractiveness Analysis by Sample, 2023 to 2033

Figure 170: South Asia Market Attractiveness Analysis by Product, 2023 to 2033

Figure 171: South Asia Market Attractiveness Analysis by End User, 2023 to 2033

Figure 172: South Asia Market Attractiveness Analysis by Country, 2023 to 2033

Figure 173: India Market Value Proportion Analysis, 2022

Figure 174: Global Vs. India Growth Comparison, 2022 to 2033

Figure 175: India Market Share Analysis (%) by Test Type, 2022 & 2033

Figure 176: India Market Share Analysis (%) by Sample, 2022 & 2033

Figure 177: India Market Share Analysis (%) by Product, 2022 & 2033

Figure 178: India Market Share Analysis (%) by End User, 2022 & 2033

Figure 179: Indonesia Market Value Proportion Analysis, 2022

Figure 180: Global Vs. Indonesia Growth Comparison, 2022 to 2033

Figure 181: Indonesia Market Share Analysis (%) by Test Type, 2022 & 2033

Figure 182: Indonesia Market Share Analysis (%) by Sample, 2022 & 2033

Figure 183: Indonesia Market Share Analysis (%) by Product, 2022 & 2033

Figure 184: Indonesia Market Share Analysis (%) by End User, 2022 & 2033

Figure 185: Malaysia Market Value Proportion Analysis, 2022

Figure 186: Global Vs. Malaysia Growth Comparison, 2022 to 2033

Figure 187: Malaysia Market Share Analysis (%) by Test Type, 2022 & 2033

Figure 188: Malaysia Market Share Analysis (%) by Sample, 2022 & 2033

Figure 189: Malaysia Market Share Analysis (%) by Product, 2022 & 2033

Figure 190: Malaysia Market Share Analysis (%) by End User, 2022 & 2033

Figure 191: Thailand Market Value Proportion Analysis, 2022

Figure 192: Global Vs. Thailand Growth Comparison, 2022 to 2033

Figure 193: Thailand Market Share Analysis (%) by Test Type, 2022 & 2033

Figure 194: Thailand Market Share Analysis (%) by Sample, 2022 & 2033

Figure 195: Thailand Market Share Analysis (%) by Product, 2022 & 2033

Figure 196: Thailand Market Share Analysis (%) by End User, 2022 & 2033

Figure 197: Oceania Market Value (US$ Million) Analysis, 2012 to 2022

Figure 198: Oceania Market Value (US$ Million) Forecast, 2023 to 2033

Figure 199: Oceania Market Value Share, by Test Type (2023 E)

Figure 200: Oceania Market Value Share, by Sample (2023 E)

Figure 201: Oceania Market Value Share, by Product (2023 E)

Figure 202: Oceania Market Value Share, by End User (2023 E)

Figure 203: Oceania Market Value Share, by Country (2023 E)

Figure 204: Oceania Market Attractiveness Analysis by Test Type, 2023 to 2033

Figure 205: Oceania Market Attractiveness Analysis by Sample, 2023 to 2033

Figure 206: Oceania Market Attractiveness Analysis by Product, 2023 to 2033

Figure 207: Oceania Market Attractiveness Analysis by End User, 2023 to 2033

Figure 208: Oceania Market Attractiveness Analysis by Country, 2023 to 2033

Figure 209: Australia Market Value Proportion Analysis, 2022

Figure 210: Global Vs. Australia Growth Comparison, 2022 to 2033

Figure 211: Australia Market Share Analysis (%) by Test Type, 2022 & 2033

Figure 212: Australia Market Share Analysis (%) by Sample, 2022 & 2033

Figure 213: Australia Market Share Analysis (%) by Product, 2022 & 2033

Figure 214: Australia Market Share Analysis (%) by End User, 2022 & 2033

Figure 215: New Zealand Market Value Proportion Analysis, 2022

Figure 216: Global Vs New Zealand Growth Comparison, 2022 to 2033

Figure 217: New Zealand Market Share Analysis (%) by Test Type, 2022 & 2033

Figure 218: New Zealand Market Share Analysis (%) by Sample, 2022 & 2033

Figure 219: New Zealand Market Share Analysis (%) by Product, 2022 & 2033

Figure 220: New Zealand Market Share Analysis (%) by End User, 2022 & 2033

Figure 221: Middle East and Africa Market Value (US$ Million) Analysis, 2012 to 2022

Figure 222: Middle East and Africa Market Value (US$ Million) Forecast, 2023 to 2033

Figure 223: Middle East and Africa Market Value Share, by Test Type (2023 E)

Figure 224: Middle East and Africa Market Value Share, by Sample (2023 E)

Figure 225: Middle East and Africa Market Value Share, by Product (2023 E)

Figure 226: Middle East and Africa Market Value Share, by End User (2023 E)

Figure 227: Middle East and Africa Market Value Share, by Country (2023 E)

Figure 228: Middle East and Africa Market Attractiveness Analysis by Test Type, 2023 to 2033

Figure 229: Middle East and Africa Market Attractiveness Analysis by Sample, 2023 to 2033

Figure 230: Middle East and Africa Market Attractiveness Analysis by Product, 2023 to 2033

Figure 231: Middle East and Africa Market Attractiveness Analysis by End User, 2023 to 2033

Figure 232: Middle East and Africa Market Attractiveness Analysis by Country, 2023 to 2033

Figure 233: GCC Country Market Value Proportion Analysis, 2022

Figure 234: Global Vs GCC Country Growth Comparison, 2022 to 2033

Figure 235: GCC Country Market Share Analysis (%) by Test Type, 2022 & 2033

Figure 236: GCC Country Market Share Analysis (%) by Sample, 2022 & 2033

Figure 237: GCC Country Market Share Analysis (%) by Product, 2022 & 2033

Figure 238: GCC Country Market Share Analysis (%) by End User, 2022 & 2033

Figure 239: Türkiye Market Value Proportion Analysis, 2022

Figure 240: Global Vs. Türkiye Growth Comparison, 2022 to 2033

Figure 241: Türkiye Market Share Analysis (%) by Test Type, 2022 & 2033

Figure 242: Türkiye Market Share Analysis (%) by Sample, 2022 & 2033

Figure 243: Türkiye Market Share Analysis (%) by Product, 2022 & 2033

Figure 244: Türkiye Market Share Analysis (%) by End User, 2022 & 2033

Figure 245: South Africa Market Value Proportion Analysis, 2022

Figure 246: Global Vs. South Africa Growth Comparison, 2022 to 2033

Figure 247: South Africa Market Share Analysis (%) by Test Type, 2022 & 2033

Figure 248: South Africa Market Share Analysis (%) by Sample, 2022 & 2033

Figure 249: South Africa Market Share Analysis (%) by Product, 2022 & 2033

Figure 250: South Africa Market Share Analysis (%) by End User, 2022 & 2033